WASHINGTON, Sept 9 (Reuters) - U.S. infectious disease
expert Anthony Fauci said on Wednesday that AstraZeneca's
decision to pause global trials of its experimental coronavirus
vaccine was unfortunate but not an uncommon safety precaution in
a vaccine development process.
"It's really one of the safety valves that you have on
clinical trials such as this, so it's unfortunate that it
happened," Fauci told CBS "This Morning" in an interview.
"Hopefully, they'll work it out and be able to proceed along
with the remainder of the trial but you don't know. They need to
investigate it further."
(Reporting by Doina Chiacu; Editing by Andrew Heavens)
Astrazeneca (AZN)
